Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 71 | 2024 | 1597 | 11.310 |
Why?
|
Epoprostenol | 17 | 2024 | 246 | 6.270 |
Why?
|
Exercise Tolerance | 25 | 2024 | 848 | 4.150 |
Why?
|
Pulmonary Artery | 28 | 2024 | 1945 | 3.440 |
Why?
|
Lung Diseases, Interstitial | 11 | 2024 | 945 | 3.410 |
Why?
|
Antihypertensive Agents | 19 | 2024 | 2027 | 2.880 |
Why?
|
Vascular Resistance | 20 | 2023 | 940 | 2.420 |
Why?
|
Ventricular Function, Right | 8 | 2024 | 628 | 2.190 |
Why?
|
Exercise Test | 25 | 2024 | 2186 | 2.130 |
Why?
|
Hyperoxia | 10 | 2010 | 261 | 1.980 |
Why?
|
Phosphodiesterase 5 Inhibitors | 5 | 2020 | 103 | 1.910 |
Why?
|
Ventricular Dysfunction, Right | 7 | 2021 | 644 | 1.340 |
Why?
|
Pulmonary Wedge Pressure | 12 | 2024 | 275 | 1.320 |
Why?
|
Hemodynamics | 15 | 2024 | 4199 | 1.230 |
Why?
|
Pulmonary Circulation | 9 | 2022 | 744 | 1.220 |
Why?
|
Stroke Volume | 15 | 2021 | 5619 | 1.210 |
Why?
|
Prostaglandins I | 2 | 2020 | 12 | 1.160 |
Why?
|
Dyspnea | 7 | 2021 | 1351 | 1.040 |
Why?
|
Ventricular Pressure | 4 | 2021 | 210 | 1.000 |
Why?
|
Interleukin-6 | 10 | 2009 | 3230 | 0.960 |
Why?
|
Recombinant Fusion Proteins | 6 | 2024 | 3731 | 0.930 |
Why?
|
Interleukin-11 | 6 | 2008 | 59 | 0.910 |
Why?
|
Heart Failure | 12 | 2021 | 11858 | 0.890 |
Why?
|
Diagnostic Techniques, Cardiovascular | 2 | 2016 | 153 | 0.850 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2022 | 62 | 0.780 |
Why?
|
Administration, Inhalation | 5 | 2024 | 1169 | 0.770 |
Why?
|
Tricuspid Valve | 4 | 2019 | 419 | 0.750 |
Why?
|
Heart Ventricles | 10 | 2021 | 3838 | 0.690 |
Why?
|
Transforming Growth Factor beta | 3 | 2024 | 2003 | 0.690 |
Why?
|
Exercise | 19 | 2023 | 5946 | 0.680 |
Why?
|
Infusion Pumps, Implantable | 2 | 2017 | 158 | 0.660 |
Why?
|
Gelsolin | 3 | 2008 | 189 | 0.610 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2019 | 362 | 0.610 |
Why?
|
Acute Lung Injury | 4 | 2010 | 378 | 0.610 |
Why?
|
Cytoprotection | 2 | 2009 | 200 | 0.600 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2021 | 452 | 0.600 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2106 | 0.590 |
Why?
|
Oxygen Consumption | 8 | 2024 | 1882 | 0.570 |
Why?
|
Lung | 17 | 2022 | 10089 | 0.570 |
Why?
|
Lung Diseases | 5 | 2017 | 1925 | 0.560 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 520 | 0.530 |
Why?
|
Pulmonary Alveoli | 2 | 2010 | 665 | 0.520 |
Why?
|
Pulmonary Medicine | 1 | 2018 | 223 | 0.510 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2024 | 3243 | 0.510 |
Why?
|
Oxygen | 12 | 2022 | 4273 | 0.460 |
Why?
|
Humans | 139 | 2025 | 768393 | 0.450 |
Why?
|
Endpoint Determination | 1 | 2015 | 594 | 0.420 |
Why?
|
Catheterization, Central Venous | 1 | 2017 | 536 | 0.390 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 941 | 0.390 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2017 | 507 | 0.390 |
Why?
|
Respiratory Function Tests | 4 | 2021 | 1696 | 0.370 |
Why?
|
Fatigue Syndrome, Chronic | 2 | 2023 | 217 | 0.360 |
Why?
|
Anticoagulants | 2 | 2017 | 4843 | 0.360 |
Why?
|
Ventricular Function, Left | 3 | 2019 | 3941 | 0.350 |
Why?
|
Treatment Outcome | 19 | 2024 | 65379 | 0.350 |
Why?
|
Double-Blind Method | 9 | 2024 | 12456 | 0.350 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2018 | 954 | 0.340 |
Why?
|
Aged | 56 | 2024 | 171562 | 0.340 |
Why?
|
Female | 82 | 2024 | 397089 | 0.330 |
Why?
|
Respiratory Mucosa | 3 | 2010 | 439 | 0.320 |
Why?
|
Male | 82 | 2025 | 364902 | 0.320 |
Why?
|
Middle Aged | 65 | 2024 | 223491 | 0.320 |
Why?
|
MAP Kinase Kinase Kinase 5 | 1 | 2008 | 20 | 0.320 |
Why?
|
Mitochondrial Proteins | 2 | 2019 | 977 | 0.320 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2009 | 71 | 0.320 |
Why?
|
Sulfones | 1 | 2011 | 448 | 0.310 |
Why?
|
bcl-2-Associated X Protein | 2 | 2009 | 282 | 0.310 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2008 | 109 | 0.310 |
Why?
|
DNA Fragmentation | 2 | 1999 | 240 | 0.300 |
Why?
|
Cell Membrane Permeability | 1 | 2010 | 574 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2009 | 1409 | 0.290 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 178 | 0.290 |
Why?
|
Hydrogen Peroxide | 3 | 2009 | 742 | 0.290 |
Why?
|
Signal Transduction | 9 | 2024 | 23631 | 0.280 |
Why?
|
Cardiology | 1 | 2018 | 1701 | 0.270 |
Why?
|
Pulmonary Gas Exchange | 6 | 2020 | 389 | 0.270 |
Why?
|
Disease Progression | 3 | 2022 | 13646 | 0.270 |
Why?
|
Calcium Channel Blockers | 2 | 2007 | 692 | 0.260 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 213 | 0.260 |
Why?
|
Prostaglandins | 1 | 2007 | 398 | 0.260 |
Why?
|
Echocardiography, Doppler | 3 | 2017 | 899 | 0.250 |
Why?
|
Caspase 3 | 1 | 2008 | 731 | 0.250 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2016 | 2144 | 0.250 |
Why?
|
GTP Phosphohydrolases | 1 | 2009 | 525 | 0.250 |
Why?
|
Protein C | 1 | 2005 | 134 | 0.240 |
Why?
|
Isoxazoles | 1 | 2007 | 233 | 0.240 |
Why?
|
Pulmonary Embolism | 3 | 2022 | 2587 | 0.230 |
Why?
|
Piperazines | 2 | 2014 | 2552 | 0.230 |
Why?
|
Myocardium | 3 | 2017 | 4788 | 0.230 |
Why?
|
Mice, Transgenic | 13 | 2012 | 9562 | 0.230 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2008 | 329 | 0.220 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2014 | 1493 | 0.220 |
Why?
|
Adult | 52 | 2024 | 223640 | 0.220 |
Why?
|
Activin Receptors, Type II | 1 | 2024 | 123 | 0.220 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 2003 | 28 | 0.220 |
Why?
|
Least-Squares Analysis | 2 | 2021 | 368 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2019 | 2911 | 0.220 |
Why?
|
Membrane Transport Proteins | 1 | 2009 | 1034 | 0.210 |
Why?
|
Endothelial Cells | 9 | 2025 | 3587 | 0.210 |
Why?
|
Bile Acids and Salts | 1 | 2025 | 400 | 0.200 |
Why?
|
Thiophenes | 1 | 2007 | 569 | 0.200 |
Why?
|
Shock, Septic | 2 | 2007 | 774 | 0.200 |
Why?
|
Systole | 3 | 2021 | 937 | 0.200 |
Why?
|
Organizational Affiliation | 1 | 2001 | 34 | 0.200 |
Why?
|
Echocardiography | 8 | 2021 | 5044 | 0.200 |
Why?
|
Actins | 2 | 2008 | 2059 | 0.190 |
Why?
|
Radionuclide Imaging | 13 | 2003 | 1998 | 0.190 |
Why?
|
Infusions, Intravenous | 4 | 2017 | 2226 | 0.190 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2021 | 57 | 0.190 |
Why?
|
Perfusion Imaging | 2 | 2022 | 196 | 0.190 |
Why?
|
MicroRNAs | 5 | 2015 | 3804 | 0.190 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8051 | 0.190 |
Why?
|
Anaerobic Threshold | 2 | 2019 | 52 | 0.190 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1890 | 0.190 |
Why?
|
Connecticut | 1 | 2021 | 365 | 0.180 |
Why?
|
Medication Adherence | 1 | 2012 | 2189 | 0.180 |
Why?
|
Schistosomiasis | 1 | 2021 | 65 | 0.180 |
Why?
|
Recovery of Function | 2 | 2024 | 2990 | 0.180 |
Why?
|
Animals | 32 | 2025 | 169337 | 0.180 |
Why?
|
Endothelium | 1 | 2003 | 768 | 0.180 |
Why?
|
Pulmonary Ventilation | 2 | 2019 | 376 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2460 | 0.170 |
Why?
|
Public Sector | 1 | 2001 | 266 | 0.170 |
Why?
|
Cells, Cultured | 12 | 2019 | 19022 | 0.170 |
Why?
|
Retrospective Studies | 13 | 2024 | 81801 | 0.170 |
Why?
|
Vasodilator Agents | 4 | 2020 | 990 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2884 | 0.170 |
Why?
|
Aldosterone | 2 | 2016 | 881 | 0.160 |
Why?
|
Lysosomes | 1 | 2025 | 939 | 0.160 |
Why?
|
Iron-Sulfur Proteins | 2 | 2019 | 85 | 0.160 |
Why?
|
Respiratory Insufficiency | 2 | 2008 | 1241 | 0.160 |
Why?
|
Survival Rate | 8 | 2021 | 12870 | 0.150 |
Why?
|
Vital Capacity | 1 | 2021 | 984 | 0.150 |
Why?
|
Private Sector | 1 | 2001 | 396 | 0.150 |
Why?
|
Oxidants | 2 | 2009 | 168 | 0.150 |
Why?
|
Utah | 1 | 2018 | 130 | 0.150 |
Why?
|
Mice | 23 | 2025 | 82017 | 0.150 |
Why?
|
Up-Regulation | 4 | 2021 | 4142 | 0.150 |
Why?
|
Collagen Type III | 1 | 2018 | 92 | 0.150 |
Why?
|
Sepsis | 2 | 2010 | 2601 | 0.150 |
Why?
|
Extracellular Matrix | 2 | 2016 | 1739 | 0.150 |
Why?
|
Cell Death | 3 | 2005 | 1682 | 0.150 |
Why?
|
Atrial Function | 1 | 2018 | 99 | 0.150 |
Why?
|
Anti-Infective Agents | 1 | 2005 | 985 | 0.150 |
Why?
|
Connective Tissue Diseases | 1 | 2021 | 285 | 0.150 |
Why?
|
Blood Pressure | 5 | 2017 | 8541 | 0.150 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39407 | 0.150 |
Why?
|
Oxidative Stress | 1 | 2009 | 3139 | 0.140 |
Why?
|
Time Factors | 11 | 2017 | 40272 | 0.140 |
Why?
|
Prognosis | 7 | 2021 | 30022 | 0.140 |
Why?
|
Injections, Intra-Arterial | 1 | 2017 | 181 | 0.140 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2009 | 440 | 0.140 |
Why?
|
Verapamil | 1 | 1997 | 242 | 0.140 |
Why?
|
Guideline Adherence | 2 | 2022 | 2240 | 0.140 |
Why?
|
Ventricular Function | 2 | 2018 | 406 | 0.140 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2017 | 86 | 0.140 |
Why?
|
Pyridines | 1 | 2008 | 2889 | 0.140 |
Why?
|
Gastric Emptying | 1 | 1999 | 246 | 0.130 |
Why?
|
Microvessels | 1 | 2021 | 586 | 0.130 |
Why?
|
Quality of Life | 4 | 2023 | 13503 | 0.130 |
Why?
|
Vascular Diseases | 2 | 2022 | 1161 | 0.130 |
Why?
|
Echocardiography, Stress | 1 | 2017 | 139 | 0.130 |
Why?
|
Mitochondria | 2 | 2009 | 3675 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 325 | 0.130 |
Why?
|
DNA Damage | 1 | 2006 | 2458 | 0.130 |
Why?
|
Aortography | 1 | 2017 | 422 | 0.130 |
Why?
|
Cardiac Output | 3 | 2015 | 838 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2024 | 2353 | 0.130 |
Why?
|
International Normalized Ratio | 1 | 2017 | 382 | 0.130 |
Why?
|
Propranolol | 1 | 1997 | 493 | 0.130 |
Why?
|
Aged, 80 and over | 9 | 2021 | 59686 | 0.130 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 22355 | 0.130 |
Why?
|
Glycine | 1 | 2019 | 672 | 0.130 |
Why?
|
Sex Distribution | 1 | 2021 | 2281 | 0.130 |
Why?
|
World Health Organization | 1 | 2001 | 1327 | 0.120 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1997 | 242 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10377 | 0.120 |
Why?
|
Drug Industry | 1 | 2001 | 793 | 0.120 |
Why?
|
Cooperative Behavior | 2 | 2018 | 1515 | 0.120 |
Why?
|
Lipid Peroxidation | 3 | 2009 | 276 | 0.120 |
Why?
|
Sulfur | 1 | 2015 | 160 | 0.120 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2017 | 262 | 0.120 |
Why?
|
Posture | 2 | 2017 | 956 | 0.120 |
Why?
|
Survival Analysis | 3 | 2024 | 10117 | 0.110 |
Why?
|
Interdisciplinary Communication | 2 | 2018 | 937 | 0.110 |
Why?
|
Heart | 6 | 2023 | 4449 | 0.110 |
Why?
|
Thallium Radioisotopes | 5 | 1993 | 139 | 0.110 |
Why?
|
Mechanotransduction, Cellular | 2 | 2016 | 542 | 0.110 |
Why?
|
Apoptosis | 6 | 2016 | 9516 | 0.110 |
Why?
|
Protein Transport | 2 | 2010 | 1958 | 0.110 |
Why?
|
Phenylpropionates | 1 | 2013 | 34 | 0.110 |
Why?
|
Cyclic GMP-Dependent Protein Kinases | 1 | 2013 | 28 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2001 | 873 | 0.110 |
Why?
|
Myocardial Contraction | 2 | 2018 | 1527 | 0.110 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1997 | 664 | 0.110 |
Why?
|
Feedback, Physiological | 1 | 2015 | 481 | 0.110 |
Why?
|
Community Pharmacy Services | 1 | 2012 | 52 | 0.100 |
Why?
|
Cytomegalovirus | 1 | 1997 | 754 | 0.100 |
Why?
|
Phosphoproteins | 2 | 2018 | 2448 | 0.100 |
Why?
|
Cell Proliferation | 5 | 2017 | 10478 | 0.100 |
Why?
|
Carbolines | 1 | 2014 | 296 | 0.100 |
Why?
|
Heart Conduction System | 1 | 1997 | 1009 | 0.100 |
Why?
|
Vasoconstriction | 1 | 2014 | 594 | 0.100 |
Why?
|
Rats | 9 | 2021 | 23835 | 0.100 |
Why?
|
Cardiac Output, Low | 1 | 2012 | 191 | 0.100 |
Why?
|
Membrane Proteins | 1 | 2009 | 7880 | 0.100 |
Why?
|
Purines | 2 | 2014 | 615 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 6 | 2021 | 8199 | 0.100 |
Why?
|
Cardiac Surgical Procedures | 1 | 2007 | 3681 | 0.100 |
Why?
|
Endothelium, Vascular | 2 | 2025 | 4427 | 0.090 |
Why?
|
Pyridazines | 1 | 2013 | 203 | 0.090 |
Why?
|
Drug Substitution | 1 | 2014 | 291 | 0.090 |
Why?
|
In Situ Nick-End Labeling | 3 | 2008 | 612 | 0.090 |
Why?
|
Risk Assessment | 3 | 2021 | 24318 | 0.090 |
Why?
|
Sulfonamides | 2 | 2014 | 1980 | 0.090 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14784 | 0.090 |
Why?
|
Fibrosis | 1 | 2018 | 2077 | 0.090 |
Why?
|
Dietary Fats | 1 | 1999 | 2003 | 0.090 |
Why?
|
Medication Therapy Management | 1 | 2012 | 131 | 0.090 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 518 | 0.090 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2524 | 0.090 |
Why?
|
Patient Positioning | 3 | 2020 | 332 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 1226 | 0.090 |
Why?
|
Injections, Subcutaneous | 2 | 2023 | 687 | 0.090 |
Why?
|
Lung Injury | 2 | 2005 | 433 | 0.090 |
Why?
|
Respiration Disorders | 1 | 2013 | 366 | 0.090 |
Why?
|
Hospital Mortality | 2 | 2015 | 5367 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2021 | 10776 | 0.090 |
Why?
|
Cytomegalovirus Infections | 1 | 1997 | 839 | 0.090 |
Why?
|
Diuretics | 1 | 2013 | 612 | 0.090 |
Why?
|
Aorta | 1 | 2017 | 2046 | 0.080 |
Why?
|
Reproducibility of Results | 6 | 2017 | 20224 | 0.080 |
Why?
|
Nitric Oxide | 2 | 2022 | 2144 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1110 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20765 | 0.080 |
Why?
|
Spironolactone | 1 | 2013 | 412 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2505 | 0.080 |
Why?
|
Catheterization, Peripheral | 1 | 2013 | 346 | 0.080 |
Why?
|
Hyperaldosteronism | 1 | 2012 | 250 | 0.080 |
Why?
|
Administration, Oral | 2 | 2015 | 4039 | 0.080 |
Why?
|
ROC Curve | 4 | 2018 | 3623 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1881 | 0.080 |
Why?
|
Emergency Treatment | 1 | 2013 | 496 | 0.080 |
Why?
|
TNF Receptor-Associated Death Domain Protein | 1 | 2008 | 5 | 0.080 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2000 | 761 | 0.080 |
Why?
|
Phosphoserine | 1 | 2009 | 204 | 0.080 |
Why?
|
Blood Cells | 1 | 2010 | 308 | 0.080 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2008 | 56 | 0.080 |
Why?
|
Uteroglobin | 1 | 2008 | 56 | 0.080 |
Why?
|
Blood Transfusion | 1 | 2015 | 1309 | 0.080 |
Why?
|
DNA, Mitochondrial | 1 | 2013 | 871 | 0.080 |
Why?
|
Area Under Curve | 3 | 2017 | 1642 | 0.080 |
Why?
|
Massachusetts | 1 | 2021 | 8902 | 0.080 |
Why?
|
APACHE | 1 | 2008 | 268 | 0.080 |
Why?
|
Insurance Claim Review | 1 | 2012 | 746 | 0.070 |
Why?
|
Caspase 8 | 1 | 2008 | 198 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 11918 | 0.070 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2008 | 199 | 0.070 |
Why?
|
Arterioles | 1 | 2008 | 252 | 0.070 |
Why?
|
Ultrasonography | 2 | 2018 | 6001 | 0.070 |
Why?
|
Mitochondrial Membranes | 1 | 2009 | 185 | 0.070 |
Why?
|
PPAR gamma | 3 | 2015 | 487 | 0.070 |
Why?
|
Placenta | 1 | 2017 | 1723 | 0.070 |
Why?
|
Pilot Projects | 5 | 2018 | 8731 | 0.070 |
Why?
|
Macrophages, Alveolar | 1 | 2010 | 415 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 257 | 0.070 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2009 | 167 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2931 | 0.070 |
Why?
|
Asthma | 1 | 2006 | 6280 | 0.070 |
Why?
|
Swine | 1 | 2017 | 5994 | 0.070 |
Why?
|
Gene Regulatory Networks | 2 | 2014 | 1753 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2066 | 0.070 |
Why?
|
Sex Factors | 2 | 2021 | 10654 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2529 | 0.070 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2016 | 703 | 0.070 |
Why?
|
Microtubule-Associated Proteins | 2 | 2008 | 1078 | 0.070 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1112 | 0.070 |
Why?
|
United States | 6 | 2021 | 73150 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1671 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2013 | 1539 | 0.070 |
Why?
|
Citrates | 2 | 2005 | 134 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2890 | 0.070 |
Why?
|
Clinical Protocols | 1 | 2012 | 1445 | 0.060 |
Why?
|
Coculture Techniques | 1 | 2010 | 1342 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 325 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 692 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 3813 | 0.060 |
Why?
|
Potassium | 1 | 2010 | 1318 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 3434 | 0.060 |
Why?
|
Endotoxemia | 1 | 2007 | 198 | 0.060 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2005 | 68 | 0.060 |
Why?
|
Hyperplasia | 1 | 2008 | 1153 | 0.060 |
Why?
|
Gallium | 1 | 2005 | 30 | 0.060 |
Why?
|
Dioxoles | 1 | 2005 | 96 | 0.060 |
Why?
|
Severity of Illness Index | 6 | 2021 | 15939 | 0.060 |
Why?
|
Protein Interaction Mapping | 1 | 2009 | 612 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9371 | 0.060 |
Why?
|
STAT3 Transcription Factor | 2 | 2014 | 875 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2018 | 3627 | 0.060 |
Why?
|
Prospective Studies | 7 | 2021 | 54920 | 0.060 |
Why?
|
Intensive Care Units | 3 | 2013 | 3801 | 0.060 |
Why?
|
Thallium | 6 | 1987 | 100 | 0.060 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2025 | 62 | 0.060 |
Why?
|
Antioxidants | 3 | 2003 | 1673 | 0.060 |
Why?
|
Pregnancy | 2 | 2017 | 30200 | 0.060 |
Why?
|
Aortitis | 1 | 2005 | 77 | 0.060 |
Why?
|
Cohort Studies | 4 | 2024 | 41795 | 0.060 |
Why?
|
Organ Specificity | 1 | 2009 | 1967 | 0.060 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1795 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2010 | 1020 | 0.060 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2005 | 1141 | 0.060 |
Why?
|
Protein Multimerization | 1 | 2009 | 971 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2008 | 1837 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2008 | 1246 | 0.060 |
Why?
|
Isoquinolines | 1 | 2005 | 354 | 0.060 |
Why?
|
Adenosine Triphosphate | 1 | 2010 | 2002 | 0.060 |
Why?
|
Thrombolytic Therapy | 2 | 2022 | 2050 | 0.050 |
Why?
|
Radioisotopes | 7 | 1987 | 517 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 415 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2009 | 1151 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2006 | 1703 | 0.050 |
Why?
|
DEAE-Dextran | 1 | 2023 | 9 | 0.050 |
Why?
|
Respiratory System Agents | 1 | 2023 | 30 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2008 | 998 | 0.050 |
Why?
|
Legionnaires' Disease | 1 | 2003 | 50 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2009 | 3587 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2012 | 7453 | 0.050 |
Why?
|
Systems Biology | 2 | 2018 | 479 | 0.050 |
Why?
|
Gene Silencing | 1 | 2009 | 1503 | 0.050 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2006 | 417 | 0.050 |
Why?
|
Pyridostigmine Bromide | 1 | 2022 | 32 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6670 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2514 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21544 | 0.050 |
Why?
|
Animals, Newborn | 1 | 2008 | 2695 | 0.050 |
Why?
|
Stress, Physiological | 2 | 2009 | 1410 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 1967 | 0.050 |
Why?
|
Models, Biological | 2 | 2015 | 9493 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2008 | 3520 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2013 | 6318 | 0.050 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2005 | 618 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3541 | 0.050 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2003 | 331 | 0.050 |
Why?
|
Acute Disease | 3 | 2022 | 7242 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18362 | 0.050 |
Why?
|
Pneumonia | 2 | 2003 | 2163 | 0.050 |
Why?
|
Epithelium | 1 | 2006 | 1609 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3953 | 0.050 |
Why?
|
Physical Exertion | 3 | 2014 | 669 | 0.050 |
Why?
|
Rest | 2 | 2016 | 951 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15455 | 0.050 |
Why?
|
Resuscitation | 1 | 2005 | 679 | 0.050 |
Why?
|
Endocarditis | 1 | 2005 | 352 | 0.040 |
Why?
|
Trans-Activators | 2 | 2016 | 2856 | 0.040 |
Why?
|
Odds Ratio | 1 | 2012 | 9682 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 637 | 0.040 |
Why?
|
Cattle | 1 | 2006 | 3826 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2006 | 1748 | 0.040 |
Why?
|
Young Adult | 6 | 2019 | 60049 | 0.040 |
Why?
|
Computational Biology | 1 | 2012 | 3543 | 0.040 |
Why?
|
Prosthesis-Related Infections | 1 | 2005 | 494 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16721 | 0.040 |
Why?
|
Adolescent | 9 | 2021 | 89184 | 0.040 |
Why?
|
Transcription Factors | 2 | 2016 | 12166 | 0.040 |
Why?
|
|